180 related articles for article (PubMed ID: 27498064)
41. [Clinicopathologic study of a family cherubism].
Meng XM; Yu SF; Wu YT
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Nov; 39(6):475-7. PubMed ID: 15854318
[TBL] [Abstract][Full Text] [Related]
42. Saliva suppresses osteoclastogenesis in murine bone marrow cultures.
Caballé-Serrano J; Cvikl B; Bosshardt DD; Buser D; Lussi A; Gruber R
J Dent Res; 2015 Jan; 94(1):192-200. PubMed ID: 25297116
[TBL] [Abstract][Full Text] [Related]
43. Clinicoradiologic follow up of cherubism with aggressive characteristics: a series of 3 cases.
Gupta S; Singh K; Garg A; Bhandari PS; Sah SK; Reichenberger E; Kapoor S; Jain S; Trehanpati N
Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Nov; 128(5):e191-e201. PubMed ID: 30904497
[TBL] [Abstract][Full Text] [Related]
44. Expression of cathepsin K and tartrate-resistant acid phosphatase is not confined to osteoclasts but is a general feature of multinucleated giant cells: systematic analysis.
Park JK; Rosen A; Saffitz JE; Asimaki A; Litovsky SH; Mackey-Bojack SM; Halushka MK
Rheumatology (Oxford); 2013 Aug; 52(8):1529-33. PubMed ID: 23674817
[TBL] [Abstract][Full Text] [Related]
45. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
[TBL] [Abstract][Full Text] [Related]
46. [Molecular and Cellular Pathogenesis of Cherubism].
Ueki Y
Clin Calcium; 2016 Jun; 26(6):918-26. PubMed ID: 27230848
[TBL] [Abstract][Full Text] [Related]
47. Anti-tumor necrosis factor treatment in cherubism--clinical, radiological and histological findings in two children.
Hero M; Suomalainen A; Hagström J; Stoor P; Kontio R; Alapulli H; Arte S; Toiviainen-Salo S; Lahdenne P; Mäkitie O
Bone; 2013 Jan; 52(1):347-53. PubMed ID: 23069372
[TBL] [Abstract][Full Text] [Related]
48. WWOX expression in giant cell lesions of the jaws.
Amaral FR; Diniz MG; Bernardes VF; Souza PE; Gomez RS; Gomes CC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):210-3. PubMed ID: 23849374
[TBL] [Abstract][Full Text] [Related]
49. Are CD68 and Factor VIII-RA Expression Different in Central and Peripheral Giant Cell Granuloma of Jaw: An Immunohistochemical Comparative Study.
Sargolzaei S; Taghavi N; Poursafar F
Turk Patoloji Derg; 2017; 1(1):49-56. PubMed ID: 28832079
[TBL] [Abstract][Full Text] [Related]
50. Multiple versus solitary giant cell lesions of the jaw: Similar or distinct entities?
Schreuder WH; van der Wal JE; de Lange J; van den Berg H
Bone; 2021 Aug; 149():115935. PubMed ID: 33771761
[TBL] [Abstract][Full Text] [Related]
51. Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumours of the jaw.
Idowu BD; Thomas G; Frow R; Diss TC; Flanagan AM
Br J Oral Maxillofac Surg; 2008 Apr; 46(3):229-230. PubMed ID: 17544554
[TBL] [Abstract][Full Text] [Related]
52. Cherubism: A Case Report with Surgical Intervention.
Friedrich RE; Scheuer HA; Zustin J; Grob T
Anticancer Res; 2016 Jun; 36(6):3109-15. PubMed ID: 27272835
[TBL] [Abstract][Full Text] [Related]
53. A comparative immunohistochemical evaluation of CD68 and TRAP protein expression in central and peripheral giant cell granulomas of the jaws.
Torabinia N; Razavi SM; Shokrolahi Z
J Oral Pathol Med; 2011 Apr; 40(4):334-7. PubMed ID: 21029180
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of denosumab treatment in a prepubertal patient with cherubism.
Kawamura H; Watanabe S; I T; Asahina I; Moriuchi H; Dateki S
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):963-966. PubMed ID: 32649295
[TBL] [Abstract][Full Text] [Related]
55. DNA analysis of the SH3BP2 gene in patients with aggressive central giant cell granuloma.
de Lange J; van Maarle MC; van den Akker HP; Redeker EJ
Br J Oral Maxillofac Surg; 2007 Sep; 45(6):499-500. PubMed ID: 16713042
[TBL] [Abstract][Full Text] [Related]
56. Pulsed electromagnetic field inhibits RANKL-dependent osteoclastic differentiation in RAW264.7 cells through the Ca
Zhang J; Xu H; Han Z; Chen P; Yu Q; Lei Y; Li Z; Zhao M; Tian J
Biochem Biophys Res Commun; 2017 Jan; 482(2):289-295. PubMed ID: 27856256
[TBL] [Abstract][Full Text] [Related]
57. Novel nucleotide mutation leading to a recurrent amino acid alteration in SH3BP2 in a patient with cherubism.
Sangu N; Shimosato T; Inoda H; Shimada S; Shimojima K; Ando T; Yamamoto T
Congenit Anom (Kyoto); 2013 Dec; 53(4):166-9. PubMed ID: 24712477
[TBL] [Abstract][Full Text] [Related]
58. Involvement of PU.1 in NFATc1 promoter function in osteoclast development.
Ishiyama K; Yashiro T; Nakano N; Kasakura K; Miura R; Hara M; Kawai F; Maeda K; Tamura N; Okumura K; Ogawa H; Takasaki Y; Nishiyama C
Allergol Int; 2015 Jul; 64(3):241-7. PubMed ID: 26117255
[TBL] [Abstract][Full Text] [Related]
59. Cherubism: diagnosis, treatment, and comparison with central giant cell granulomas and giant cell tumors.
Kaugars GE; Niamtu J; Svirsky JA
Oral Surg Oral Med Oral Pathol; 1992 Mar; 73(3):369-74. PubMed ID: 1545971
[TBL] [Abstract][Full Text] [Related]
60. Cherubism: a case report.
Dincă O; Severin E; Vlădan C; Bodnar DC; Bucur A
Rom J Morphol Embryol; 2014; 55(2 Suppl):655-8. PubMed ID: 25178340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
